Skip to main content
Caplight Logo









Piomic Medical AG

Piomic Medical AG

Private
ZurichHealthcare & Life Scienceshttps://www.piomic.com/

Last Round

Grant

Mar 14, 2025

Total Funding Raised

$7.82M

Company Overview

Piomic Medical AG is a medical device company that develops non-invasive therapies for hard-to-heal wounds using its proprietary COMS® One Therapy System.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

wound caremedical devicelight therapychronic wound treatmentphotobiomodulationnon-invasive therapywound healingmedtechdiabetic ulcer treatmentclinical hardwareconsumablesdermatological device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Piomic Medical AG Comparables

Compare Piomic Medical AG with similar companies based on industry and business-model similarity.

Piomic Medical AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Inotec AMD Ltd
78%
THOR Photomedicine
77%
Sky Medical Technology
71%

Piomic Medical AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 14, 2025
Series AJul 29, 2022
SeedApr 27, 2018

Key People

Founding team and executive leadership

Jari Kruth

Founder, CTO & Board Secretary

Founding Team

Martin Walti

COO

Executive Team

Piomic Medical AG Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 14, 2025

    Received funding from Bundesministerium für Bildung und Forschung and European Commission.

  • Feb 26, 2025

    Monthly visitors increased 55% MoM.

Recent news

Latest coverage and updates

  • hiresSep 18, 2026

    Piomic hires Andy Weymann as Board Observer.

  • receives_financingSep 18, 2026

    Piomic receives financing of $50M in equity, convertible capital and non-dilutive funding and grants.

  • receives_financingSep 18, 2026

    Piomic received financing of $25M in growth financing on Sep 18th '26.

Piomic Medical AG Filings

Explore SEC and related filing metadata, where available.

Piomic Medical AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersZurich
Employee Range17
Year Founded2016
Last FundingMar 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?